High Tide Inc. has secured a $40 million senior secured credit facility from a Big 5 Canadian chartered bank, comprising a $25 million revolving line and a $15 million delayed‑draw term loan. The facility, which will replace the company’s existing line with connectFirst Credit Union, is expected to close within 60 days and carries an interest rate of Prime + 2% to Prime + 3% depending on leverage.
The new facility will refinance roughly $6 million of debt owed to connectFirst and $15 million of second‑lien debentures, providing lower‑cost, institutional‑grade capital that can be deployed across High Tide’s retail expansion, the scaling of its German medical distribution platform Remexian, and other growth initiatives.
High Tide’s Q1 FY2026 results underscore the strategic timing of the financing. The company reported record revenue of $178.3 million, up 25% year‑over‑year, and record gross profit of $44.4 million. Net loss narrowed to $352 k, and free cash flow reached $2.9 million for the quarter and $16.8 million over the prior 12 months. With $46.4 million in cash and $64.5 million in debt, the new facility strengthens the balance sheet and preserves the company’s free‑cash‑flow‑positive stance while enabling accelerated expansion.
Founder and CEO Raj Grover said, “Having a Big 5 Canadian bank step in as our senior lender marks a clear inflection point for High Tide. This is not just access to capital—it is institutional validation of the scale, consistency, and quality of the business we’ve built. Our model is delivering where others have struggled, and that discipline is now translating into materially lower‑cost capital.” He added, “In a capital‑constrained industry, access to low‑cost, scalable financing is a structural advantage—and one we intend to fully leverage. This facility strengthens our ability to pursue accretive growth across our retail network, scale our German platform through Remexian, and expand into other federally legal markets, all while maintaining the disciplined financial approach that continues to set High Tide apart.”
The financing signals a strong endorsement from a major Canadian bank and provides High Tide with the flexibility to accelerate its growth strategy. Lower borrowing costs reduce interest expense, improving margin sustainability as the company expands its retail footprint and deepens its presence in the European medical cannabis market. The institutional backing also enhances investor confidence and positions High Tide to pursue additional strategic opportunities without compromising its disciplined capital structure.
The announcement represents a significant capital‑structure event that will likely influence future financial planning and strategic execution for High Tide.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.